Pomerantz LLP is investigating Phreesia, Inc. for potential securities fraud following the company's announcement of weaker-than-expected financial results and a reduced revenue forecast for fiscal 2027. The stock price dropped 26.56% after the news, reflecting investor concern over challenges in pharmaceutical marketing and the Networking Solutions segment. The investigation aims to determine if Phreesia's officers or directors engaged in unlawful business practices. Investors affected are encouraged to contact the law firm for possible class action participation.
nVent Electric plc announced a quarterly cash dividend of $0.21 per ordinary share, payable on August 7, 2026, to shareholders recorded by July 24, 2026. This dividend reflects nVent's ongoing commitment to returning value to shareholders. The compan...
OpenAI is consolidating its core AI products—ChatGPT, Codex, and its developer API—into a single product team to sharpen focus ahead of a potential IPO later this year. Greg Brockman, previously interim product lead, is now permanently in charge of p...
NextEra Energy and Dominion Energy are in talks to merge in a deal valued around $400 billion, creating one of the largest utility companies in the U.S. This merger aims to address the rapidly growing electricity demand driven by AI data centers, ind...
In 2026, the Teucrium Wheat Fund (WEAT) surged 24.29% driven by wheat-specific supply disruptions, outperforming the Invesco DB Agriculture Fund (DBA), which returned 10.7% by diversifying across multiple commodities. WEAT's gains reflect geopolitica...
Bitcoin's price dropped sharply after Strategy, Michael Saylor's bitcoin acquisition company, confirmed it might sell some of its $63 billion bitcoin holdings to fund debt repurchases and dividend payments. This announcement sparked fears of a bitcoi...
